Seth Klarman's position in Nuvation Bio is currently worth $20.6 Million. That's 0.31% of their equity portfolio (30th largest holding). The investor owns 5.13% of the outstanding Nuvation Bio stock. Seth Klarman started to build up the position in Nuvation Bio in Q1 2021 and continued to invest until Q1 2022. Since then they sold 25.3 Thousand shares. The investor's estimated purchase price is $109 Million, resulting in a loss of 81%.